Quent Capital’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,149
Closed -$118K 1345
2024
Q3
$118K Buy
+4,149
New +$104K 0.01% 454
2023
Q2
Sell
-8,000
Closed -$57.9K 1325
2023
Q1
$57.9K Hold
8,000
0.01% 556
2022
Q4
$94.3K Hold
8,000
0.02% 409
2022
Q3
$74K Buy
8,000
+2,000
+33% +$24.2K 0.02% 439
2022
Q2
$59K Buy
6,000
+3,000
+100% +$60.5K 0.01% 476
2022
Q1
$103K Buy
+3,000
New +$97.4K 0.02% 405

Other funds holding ASPN

Quent Capital's ASPN Position: Q4 2024 in Review

Quent Capital sold out of Aspen Aerogels (ASPN) in Q4 2024, closing a stake of 4,149 shares — an estimated $118K sold.

Quent Capital first reported a position in ASPN in Q1 2022 and held it in 6 quarters. The position peaked at $118K in Q3 2024. 231 funds tracked by Wall St. Rank hold ASPN as of Q4 2024.

  • Quent Capital reported no remaining Aspen Aerogels position as of Q4 2024 after selling out during the quarter.
  • Quent Capital sold 4,149 Aspen Aerogels shares in Q4 2024, an estimated $118K.
  • Quent Capital first reported a position in Aspen Aerogels in Q1 2022 and held it in 6 quarters.
  • Quent Capital's Aspen Aerogels position peaked at $118K in Q3 2024.
  • 231 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2024.

Based on Quent Capital's 13F filing for Q4 2024, filed 29 Jan 2025.